Asma Ejaz1, Frank W LoGerfo, Kamal Khabbaz, Leena Pradhan. 1. Department of Surgery, Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
OBJECTIVE: To investigate the expression of neuropeptides and their receptors that play a role in cardiac homeostasis in the right atrium of nondiabetic and diabetic patients undergoing coronary artery bypass graft surgery. BACKGROUND: The cardioactive neuropeptides and their receptors investigated in this study were Neuropeptide Y (NPY), and its receptors, NPY Receptor1 (NPY1R), NPY Receptor2 (NPY2R), NPY Receptor5 (NPY5R) and Substance P (SP) and its receptor, Neurokinin1R (NK1R). METHODS: The gene and protein expression of NPY, NPY1R, NPY2R, NPY5R, SP and NK1R from the atrial tissue of 10 nondiabetic and diabetic patients undergoing coronary artery bypass grafting (CABG) was assessed by Q-RTPCR, immunohistochemistry, Western blot, and ELISA. RESULTS: Gene expression of NPY2R, NPY5R, preproTachykinin A (SP gene), and NK1R and their respective protein expression were significantly reduced whereas that of NPY and NPY1R were unchanged in the right atrium of diabetic patients compared to nondiabetic patients. CONCLUSIONS: These results demonstrate that the expression of neuropeptides and their receptors in the diabetic heart is significantly impaired, and may be the link between neuropathy and cardiac complications. Further studies are warranted to delineate pathophysiologic mechanisms associated with dysregulation of the cardiac neuropeptide system and the relationship to cardiac complications in diabetes.
OBJECTIVE: To investigate the expression of neuropeptides and their receptors that play a role in cardiac homeostasis in the right atrium of nondiabetic and diabeticpatients undergoing coronary artery bypass graft surgery. BACKGROUND: The cardioactive neuropeptides and their receptors investigated in this study were Neuropeptide Y (NPY), and its receptors, NPY Receptor1 (NPY1R), NPY Receptor2 (NPY2R), NPY Receptor5 (NPY5R) and Substance P (SP) and its receptor, Neurokinin1R (NK1R). METHODS: The gene and protein expression of NPY, NPY1R, NPY2R, NPY5R, SP and NK1R from the atrial tissue of 10 nondiabetic and diabeticpatients undergoing coronary artery bypass grafting (CABG) was assessed by Q-RTPCR, immunohistochemistry, Western blot, and ELISA. RESULTS: Gene expression of NPY2R, NPY5R, preproTachykinin A (SP gene), and NK1R and their respective protein expression were significantly reduced whereas that of NPY and NPY1R were unchanged in the right atrium of diabeticpatients compared to nondiabeticpatients. CONCLUSIONS: These results demonstrate that the expression of neuropeptides and their receptors in the diabetic heart is significantly impaired, and may be the link between neuropathy and cardiac complications. Further studies are warranted to delineate pathophysiologic mechanisms associated with dysregulation of the cardiac neuropeptide system and the relationship to cardiac complications in diabetes.
Authors: M Chottová Dvoráková; S Wiegand; M Pesta; J Slavíková; V Grau; J Reischig; J Kuncová; W Kummer Journal: Neuroscience Date: 2007-12-08 Impact factor: 3.590
Authors: J M Pappachan; J Sebastian; B C Bino; K Jayaprakash; K Vijayakumar; P Sujathan; L A Adinegara Journal: Postgrad Med J Date: 2008-04 Impact factor: 2.401
Authors: Leena Pradhan; Xuemei Cai; Szuhuei Wu; Nicholas D Andersen; Michelle Martin; Junaid Malek; Patrick Guthrie; Aristidis Veves; Frank W Logerfo Journal: J Surg Res Date: 2009-10-23 Impact factor: 2.192
Authors: Leena Pradhan Nabzdyk; Sarada Kuchibhotla; Patrick Guthrie; Maggie Chun; Michael E Auster; Christoph Nabzdyk; Steven Deso; Nicholas Andersen; Charalambos Gnardellis; Frank W LoGerfo; Aristidis Veves Journal: J Vasc Surg Date: 2013-06-04 Impact factor: 4.268
Authors: Alexander Widiapradja; Ainsley O Kasparian; Samuel L McCaffrey; Lauren L Kolb; John D Imig; Jessica L Lacey; Giselle C Melendez; Scott P Levick Journal: Cells Date: 2021-10-05 Impact factor: 6.600